2026 Christoph Bode: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	99	8502	7989	482	461	1064	42068

Overview

Christoph Bode is affiliated with the University of Freiburg in Germany and conducts research primarily in the field of Business, Management and Accounting, with a particular focus on Strategy and Management, Management Information Systems, and Information Systems. Their work also spans Industrial and Manufacturing Engineering and Accounting.

Their research covers various main topics including Outsourcing and Supply Chain Management, Supply Chain Resilience and Risk Management, Quality and Supply Management, Software Engineering Techniques and Practices, Sustainable Supply Chain Management, Risk Management in Financial Firms, and Manufacturing Process and Optimization.

Among the frequent coauthors collaborating with Christoph Bode are Jan Martin Spreitzenbarth, Heiner Stuckenschmidt, Davide Burkhart, Ruth Schültken, and Sandro Wartzack.

They have published multiple research papers in notable venues. Recent papers include:

"Artificial intelligence and machine learning in purchasing and supply management: A mixed-methods review of the state-of-the-art in literature and practice" (2024, Journal of Purchasing and Supply Management)
"On supplier resilience: How supplier performance, disruption frequency, and disruption duration are interrelated" (2024, Journal of Purchasing and Supply Management)
"Supply disruptions and protection motivation: Why some managers act proactively (and others don't)" (2021, Journal of Business Logistics)
"Financially distressed suppliers: exit, neglect, voice or loyalty?" (2021, The International Journal of Logistics Management)
"The State of Artificial Intelligence: Procurement versus Sales and Marketing" (2022, SSRN Electronic Journal)

Christoph Bode's publication record also includes contributions to book series, notably three editions of Supply Management Research published by Advances in Supply Management in 2020, 2021, and 2022.

Their frequent publication venues include:

Academy of Management Proceedings
European Romantic Review
Journal of Purchasing and Supply Management
SSRN Electronic Journal
Procedia CIRP

Best Publications

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

Jessica L. Mega;Eugene Braunwald;Stephen D. Wiviott;Jean-Pierre Bassand

2369
Citations
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

C Michael Gibson;Roxana Mehran;Christoph Bode;Jonathan Halperin

1588
Citations
AN EMPIRICAL EXAMINATION OF SUPPLY CHAIN PERFORMANCE ALONG SEVERAL DIMENSIONS OF RISK

Stephan M. Wagner;Christoph Bode

1233
Citations
An empirical investigation into supply chain vulnerability

Stephan M. Wagner;Christoph Bode

1083
Citations
Understanding Responses to Supply Chain Disruptions: Insights from Information Processing and Resource Dependence Perspectives

Christoph Bode;Stephan M. Wagner;Kenneth J. Petersen;Lisa M. Ellram

950
Citations
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

EJ Topol;AM Lincoff;RM Califf;EM Ohman

949
Citations
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

Pierluigi Tricoci;Zhen Huang;Claes Held;David J. Moliterno

880
Citations
Chronic variable stress activates hematopoietic stem cells

Timo Heidt;Hendrik B Sager;Gabriel Courties;Partha Dutta

862
Citations
Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction

Christian Spaulding;Patrick Henry;Emmanuel Teiger;Kevin Beatt

819
Citations
Structural drivers of upstream supply chain complexity and the frequency of supply chain disruptions

Christoph Bode;Stephan M. Wagner

788
Citations
Early versus delayed, provisional eptifibatide in acute coronary syndromes.

Robert P. Giugliano;Jennifer A. White;Christoph Bode;Paul W. Armstrong

568
Citations
A COMPARISON OF HIRUDIN WITH HEPARIN IN THE PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY

Patrick W. Serruys;Jean-Paul R. Herrman;Rudiger Simon;Wolfgang Rutsch

564
Citations
Thrombolysis during Resuscitation for Out-of-Hospital Cardiac Arrest

Bernd W. Böttiger;Hans-Richard Arntz;Douglas A. Chamberlain;Erich Bluhmki

493
Citations
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.

Gilles Montalescot;Harvey D. White;Richard Gallo;Marc Cohen

454
Citations
Complementary Roles for Biomarkers of Biomechanical Strain ST2 and N-Terminal Prohormone B-Type Natriuretic Peptide in Patients With ST-Elevation Myocardial Infarction

Marc S. Sabatine;David A. Morrow;Luke J. Higgins;Catherine MacGillivray

423
Citations
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial.

Bernd W Böttiger;Christoph Bode;Christoph Bode;Sabine Kern;André Gries

404
Citations
The Effects of Serotonin in Immune Cells

Nadine Herr;Christoph Bode;Daniel Duerschmied

387
Citations
More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction

Richard W. Smalling;Christoph Bode;John Kalbfleisch;Semi Sen

376
Citations
Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice

Daniel Duerschmied;Georgette L. Suidan;Georgette L. Suidan;Melanie Demers;Melanie Demers;Nadine Herr

338
Citations
Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL) Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size

E. Regar;P.W. Serruys;C. Bode;C. Holubarsch

331
Citations

Frequent Co-Authors

Karlheinz Peter Baker IDI Heart and Diabetes Institute

Friedhelm Beyersdorf University of Freiburg

Manfred Olschewski University of Freiburg

C. Michael Gibson Beth Israel Deaconess Medical Center

Roxana Mehran Icahn School of Medicine at Mount Sinai

Cam Patterson University of Arkansas for Medical Sciences

Peter Libby Brigham and Women's Hospital

Marc Cohen RWJBarnabas Health

Freek W.A. Verheugt University Medical Centre Mannheim

Jan J. Piek University of Amsterdam

External Links

Personal website of Christoph Bode

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring pathways into the healthcare field doesn’t always mean going to medical school. Many students are opting for flexible online degrees and alternative career tracks that allow them to enter the workforce more quickly. For example, direct entry msn online programs are a great choice for individuals with a non-nursing background who want to become advanced practice nurses without completing a traditional BSN.

Other prospective nurses may look into more accessible options, such as online adn programs, which can provide a solid, quicker foundation in nursing and may have less competitive entry requirements. For those interested in supporting healthcare through administration, medical billing and coding schools that accept fafsa offer accessible routes, often with financial aid, leading directly to in-demand healthcare positions.

Flexibility is key, with some nursing schools removing common barriers to entry like standardized tests. Choosing a nursing school that does not require teas test lets students start their nursing journey without the stress of extra exams, further opening the doors to a healthcare career. Exploring these diverse pathways allows students to find a program that fits their academic background, learning style, and career goals.